425: Strive & Semler Scientific Merger Update

Strive, Inc. board member Avik Roy posted on X.com regarding the proposed business combination with Semler Scientific, Inc.

Summary

• A communication from Strive, Inc. board member Avik Roy was posted on X.com on October 24, 2025, concerning the proposed business combination with Semler Scientific, Inc.
• The communication includes a cautionary statement regarding forward-looking statements related to the merger, highlighting inherent risks and uncertainties.
• Forward-looking statements cover the outlook and expectations for the proposed transaction, including strategic and financial benefits, timing of closing, and successful integration of businesses.
• Various risks, uncertainties, and assumptions are detailed that could cause actual results to differ materially from anticipated outcomes.
• Investors are directed to additional information, including a Registration Statement on Form S-4 and an Information Statement/Proxy Statement/Prospectus, to be filed with the SEC.
• Information is provided on where to obtain these documents free of charge from the SEC's website, Strive's website, or Semler Scientific's website.
• Strive, Semler Scientific, and certain directors, executive officers, and employees may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.
• The communication explicitly states it is not an offer to sell or a solicitation of an offer to buy any securities or a solicitation of any vote of approval.

Sentiment

Score: 6

Explanation: The filing is a procedural communication about a merger, primarily focused on legal disclaimers and risks. While it mentions anticipated benefits, the extensive list of uncertainties and potential negative outcomes balances the sentiment towards a cautious neutral, slightly positive due to the underlying merger intent.

Positives

• The proposed transaction is expected to yield strategic benefits for the combined company.
• The proposed transaction is expected to result in financial benefits for the combined company.
• Anticipated cost savings and strategic gains are potential outcomes of the merger.

Negatives

• Actual results could differ materially from anticipated results due to various risks and uncertainties.
• There is a possibility that anticipated benefits, including cost savings and strategic gains, may not be realized when expected or at all.
• Integration of the two companies may prove more difficult, time-consuming, or costly than initially expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction will cause dilution.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships could occur.
• Changes in Strive's or Semler Scientific's share price before closing are a possibility.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized due to changes in Bitcoin treasury strategies, general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

Strive and Semler Scientific anticipate strategic and financial benefits from the proposed transaction, including cost savings and strategic gains. They expect to successfully integrate the combined businesses, though acknowledge risks regarding timing and realization of these benefits, particularly concerning Bitcoin treasury strategies and broader economic conditions.

Management Comments

• The following communication was posted on X.com by Avik Roy, Board Member of Strive, Inc., on October 24, 2025, in connection with Strives proposed business combination with Semler Scientific, Inc.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' indicates that the combined company intends to or already employs digital assets in its treasury management, aligning with a growing trend among some corporations to diversify treasury holdings into cryptocurrencies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor for the proposed transaction.

Stakeholder Impact

• Shareholders of Strive face potential dilution from the issuance of additional Class A common stock in connection with the merger.
• Customers of Strive and Semler Scientific may have adverse reactions to the proposed transaction.
• Business and employee relationships at both companies could be affected by the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.

Key Dates

Keywords

Strive, Semler Scientific, merger, acquisition, business combination, SEC filing, Form 425, forward-looking statements, Bitcoin treasury, corporate governance, risk management